Condition

Androgen-independent Prostate Cancer

ClinicalTrials.gov condition label

Clinical trials3

Recruiting0

Common interventions5

Lead sponsors shown3

Clinical trials

3 shown

Phase 1-2 Study of Onapristone in Patients With Advanced Castration-resistant Prostate CancerNCT02049190 · 2014-02-01

UNKNOWN

Analysis of the Mechanisms of Actions of Heat Shock Protein (Hsp27) Responsible of the Androgen-independent Evolution in Prostate CancerNCT02055846 · 2012-03-01

TERMINATED

Mitoxantrone ± Cetuximab 2nd Line Androgen Independent Prostate Cancer (AIPC)NCT00661492 · 2008-05-01

COMPLETED

Common interventions

abirateroneDRUG1cetuximabDRUG1MitoxantroneDRUG1onapristoneDRUG1Realisation of blood sample, urinary sample and tumor biopsyPROCEDURE1

Leading sponsors

Arno Therapeutics1Institut Paoli-Calmettes1US Oncology Research1

Trial status mix

COMPLETED1

TERMINATED1

UNKNOWN1

Phase mix

PHASE22

NA1

PHASE11

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.